Search Results 581-590 of 17401 for Oncogene
This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...
Learn about the types of tumors that make up this group of rare cancers. Find out about symptoms, causes, diagnosis and treatments.
Regorafenib is a type of drug called a kinase inhibitor. Regorafenib interferes with how some kinase proteins work. Some of these kinases in cancer cells might ...
Mayo Clinic researchers develop test to measure effect of breast cancer gene variants featured image · Orthopedics/Sports · Mayo Clinic Q&A podcast: Tackling the ...
Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Radiation ...
... oncogenic features. Surgery. 2019 Oct; 166 (4):547-555 Epub 2019 July 20. View PubMed; Kotha NV, Baumgartner JM, Veerapong J, Cloyd JM, Ahmed A, Grotz TE ...
... oncogene 1, non-receptor tyrosine kinase (ABL)-negative B lineage acute lymphoblastic leukemia. Drugs used in chemotherapy work in different ways to stop ...
The purpose of this study is to gain a better understanding of the treatment and significant morbidity associated with sinonasal cancer and identify the impact ...
The purpose of this study is to compare standard chemotherapy to therapy with CPX-351 and/or gilteritinib for patients with newly diagnosed acute myeloid ...
The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.